165 related articles for article (PubMed ID: 38102465)
1. m6A reader IGF2BP2 promotes lymphatic metastasis by stabilizing DPP4 in papillary thyroid carcinoma.
Wang W; Ding Y; Zhao Y; Li X
Cancer Gene Ther; 2024 Feb; 31(2):285-299. PubMed ID: 38102465
[TBL] [Abstract][Full Text] [Related]
2. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
3. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR.
Dong L; Geng Z; Liu Z; Tao M; Pan M; Lu X
Pathol Res Pract; 2021 Sep; 225():153550. PubMed ID: 34340128
[TBL] [Abstract][Full Text] [Related]
4. FosB recruits KAT5 to potentiate the growth and metastasis of papillary thyroid cancer in a DPP4-dependent manner.
Du J; Fu L; Ji F; Wang C; Liu S; Qiu X
Life Sci; 2020 Oct; 259():118374. PubMed ID: 32891613
[TBL] [Abstract][Full Text] [Related]
5. DPP4 gene silencing inhibits proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through suppression of the MAPK pathway.
Hu X; Chen S; Xie C; Li Z; Wu Z; You Z
J Endocrinol Invest; 2021 Aug; 44(8):1609-1623. PubMed ID: 33387351
[TBL] [Abstract][Full Text] [Related]
6. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
[TBL] [Abstract][Full Text] [Related]
7. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition.
Zhu Y; Peng X; Zhou Q; Tan L; Zhang C; Lin S; Long M
Cell Death Dis; 2022 Apr; 13(4):358. PubMed ID: 35436987
[TBL] [Abstract][Full Text] [Related]
8. Targeting IGF2BP2 Promotes Differentiation of Radioiodine Refractory Papillary Thyroid Cancer via Destabilizing RUNX2 mRNA.
Sa R; Liang R; Qiu X; He Z; Liu Z; Chen L
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267576
[TBL] [Abstract][Full Text] [Related]
9. The m6A reader IGF2BP2 promotes the progression of esophageal squamous cell carcinoma cells by increasing the stability of OCT4 mRNA.
Zhao R; Li T; Zhao X; Yang Z; Ma L; Wang X
Biochem Cell Biol; 2024 Apr; 102(2):169-178. PubMed ID: 37917979
[TBL] [Abstract][Full Text] [Related]
10. Overexpressed ZC3H13 suppresses papillary thyroid carcinoma growth through m6A modification-mediated IQGAP1 degradation.
Xie R; Chen W; Lv Y; Xu D; Huang D; Zhou T; Zhang S; Xiong C; Yu J
J Formos Med Assoc; 2023 Aug; 122(8):738-746. PubMed ID: 36739231
[TBL] [Abstract][Full Text] [Related]
11. METTL14 Facilitates the Metastasis of Pancreatic Carcinoma by Stabilizing LINC00941 in an m6A-IGF2BP2-Dependent Manner.
Lu J; Yu L; Xie N; Wu Y; Li B
J Cancer; 2023; 14(7):1117-1131. PubMed ID: 37215454
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl Peptidase-4 Stabilizes Integrin α4β1 Complex to Promote Thyroid Cancer Cell Metastasis by Activating Transforming Growth Factor-Beta Signaling Pathway.
He Q; Cao H; Zhao Y; Chen P; Wang N; Li W; Cui R; Hou P; Zhang X; Ji M
Thyroid; 2022 Nov; 32(11):1411-1422. PubMed ID: 36166219
[No Abstract] [Full Text] [Related]
13. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
[TBL] [Abstract][Full Text] [Related]
14. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic Ras/squamous cell carcinoma antigen signaling pathway activation promotes invasiveness and lymph node metastases in papillary thyroid carcinoma.
Luo D; Liu Y; Lin S; Tan L; Du Z; Long M; Zhu Y; Peng X; Zong W; Mackenzie GG; Li H; Ouyang N
Oncol Rep; 2019 Feb; 41(2):1253-1263. PubMed ID: 30535496
[TBL] [Abstract][Full Text] [Related]
16. Neuropilin-2 promotes growth and progression of papillary thyroid cancer cells.
Lee G; Kang YE; Oh C; Liu L; Jin Y; Lim MA; Won HR; Chang JW; Koo BS
Auris Nasus Larynx; 2020 Oct; 47(5):870-880. PubMed ID: 32381353
[TBL] [Abstract][Full Text] [Related]
17. m6A Writer METTL3-Mediated lncRNA LINC01125 Prevents the Malignancy of Papillary Thyroid Cancer.
He T; Xia H; Chen B; Duan Z; Huang C
Crit Rev Immunol; 2023; 43(3):43-53. PubMed ID: 37824376
[TBL] [Abstract][Full Text] [Related]
18. CircCDK1 blocking IGF2BP2-mediated m6A modification of CPPED1 promotes laryngeal squamous cell carcinoma metastasis via the PI3K/AKT signal pathway.
Li J; Cao H; Yang J; Wang B
Gene; 2023 Oct; 884():147686. PubMed ID: 37543219
[TBL] [Abstract][Full Text] [Related]
19. m
Zhao Y; Zhou Y; Qian Y; Wei W; Lin X; Mao S; Sun J; Jin J
Clin Transl Med; 2024 Apr; 14(4):e1628. PubMed ID: 38572589
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer.
Liu X; Zhang C; Wang X; Cui C; Cui H; Zhu B; Chen A; Zhang L; Xin J; Fu Q; Dionigi G; Sun H
Endocr Relat Cancer; 2023 Mar; 30(3):. PubMed ID: 36606578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
